Coronary to Myocyte Signaling

冠状动脉至心肌细胞信号传导

基本信息

  • 批准号:
    7252867
  • 负责人:
  • 金额:
    $ 43.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

Recent evidence suggests that there is an increase in superoxide production due to activation of the angiotensin II type 1 receptor and that the superoxide comes from the NADPH oxidase. This superoxide contributes to the biological effects of angiotensin II in that a portion of the hypertension during chronic angiotensin II infusion is superoxide dependent. The hypertension to angiotensin II is at least in part due to the scavenging of nitric oxide by superoxide. Thus, the link between the generation of superoxide and the reduction in the biological effects of NO has already been established. Our recent studies suggest that the regulation of cardiac metabolism, oxygen consumption and substrate uptake, is one of the important actions of NO and that this may not only be important in the regulation of cardiac efficiency in physiologic states, such as exercise and pregnancy, but that in disease states where NO is scavenged by superoxide, the decreased bioactivity of NO may contribute to the disease process. Interestingly, one of the initial biologic actions of angiotensin II was the control of blood volume, since angiotensin II promotes sodium reabsorption especially in states where salt intake is limited. Thus plasma angiotensin II levels increase in patients and experimental animals on a salt restricted diet. If a rise in plasma angiotensin II increases superoxide production and inactivates NO, and if plasma angiotensin II levels increase during low salt diet, then does a low salt diet result in a hitherto undescribed endothelial dysfunction and to alterations in cardiac metabolism? Thus we hypothesize that low salt diet results in endothelial dysfunction characterized by altered cardiac metabolism and coronary blood flow regulation subsequent to reduced NO bioactivity that is angiotensin II and superoxide dependent. In specific aim 1 we will use rats to determine changes in renal function, plasma angiotensin II, cardiac metabolism and the role of the NADPH oxidase during low salt intake. Aim 2 will use the gp91phox KO -/- and p47 -/- mouse heart to further elucidate the relationship between angiotensin II, the NADPH oxidase and NO in the control of cardiac metabolism. We will use chronically instrumented conscious dogs to determine the time course and biological basis for alterations in cardiac metabolism, specific aim3, and in cardiac substrate oxidation and metabolic gene expression, specific aim 4, during restricted salt intake reduction in NO bioactivity. We will examine the mechanism of potential endothelial dysfunction due to acute salt depletion using a diuretic. Interestingly, patients on a low salt diet may have an increase in cardiac events compared to those on normal salt intake, ie. events are inversely proportional to salt intake. Almost counter intuitively, it seems that patients on a low salt diet have a reduction in cardiac events when salt intake is increased. Thus our studies will examine the relationship between restricted salt intake and endothelial dysfunction with special reference to the role of altered NO bioactivity due to superoxide generation by the NADPH oxidase.
最近的证据表明,由于血管紧张素II 1型受体的激活,超氧化物产生增加,超氧化物来自NADPH氧化酶。这种超氧化物有助于血管紧张素II的生物学效应,因为慢性血管紧张素II输注期间的一部分高血压是超氧化物依赖性的。血管紧张素II引起的高血压至少部分是由于超氧化物对一氧化氮的清除。因此,超氧化物的产生和NO的生物效应的减少之间的联系已经建立。我们最近的研究表明,心脏代谢,氧消耗和底物摄取的调节,是NO的重要作用之一,这可能不仅是重要的生理状态下,如运动和怀孕的心脏效率的调节,但在疾病状态下,NO被清除的超氧化物,NO的生物活性降低可能有助于疾病的进程。有趣的是,血管紧张素II最初的生物学作用之一是控制血容量,因为血管紧张素II促进钠重吸收 特别是在盐摄入量受到限制的州。因此,在限盐饮食的患者和实验动物中,血浆血管紧张素II水平增加。如果血浆血管紧张素II的升高增加了超氧化物的产生并使NO失活,如果血浆血管紧张素II水平在低盐饮食期间增加,那么低盐饮食是否会导致迄今未描述的内皮功能障碍和心脏代谢的改变?因此,我们假设低盐饮食导致内皮功能障碍,其特征在于改变心脏代谢和冠状动脉血流调节,随后降低血管紧张素II和超氧化物依赖的NO生物活性。在具体目标1中,我们将使用大鼠确定低盐摄入期间肾功能、血浆血管紧张素II、心脏代谢和NADPH氧化酶的作用的变化。目的2将使用gp 91 phox KO -/-和p47 -/-小鼠心脏进一步阐明 血管紧张素II、NADPH氧化酶和NO在心脏代谢调控中的关系。我们将使用长期仪器清醒的狗,以确定时间进程和心脏代谢的变化,具体目标3,并在心脏底物氧化和代谢基因表达,具体目标4,在限制盐摄入量减少NO生物活性的生物学基础。我们将研究使用利尿剂引起急性盐耗竭导致的潜在内皮功能障碍的机制。有趣的是,与正常盐摄入量的患者相比,低盐饮食的患者可能会增加心脏事件。事件与盐的摄入量成反比。几乎与直觉相反,当盐摄入量增加时,低盐饮食的患者似乎心脏事件减少。因此,我们的研究将审查限制盐的摄入量和内皮功能障碍之间的关系,特别是参考的作用,改变NO的生物活性,由于超氧化物生成的NADPH氧化酶。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Thomas H HINTZE其他文献

Thomas H HINTZE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Thomas H HINTZE', 18)}}的其他基金

ENDOTHELIAL DYSFUNCTION AND A LOW SALT DIET
内皮功能障碍和低盐饮食
  • 批准号:
    7132464
  • 财政年份:
    2006
  • 资助金额:
    $ 43.64万
  • 项目类别:
CORONARY TO MYOCYTE SIGNALING
冠状动脉至心肌细胞信号传导
  • 批准号:
    6931015
  • 财政年份:
    2004
  • 资助金额:
    $ 43.64万
  • 项目类别:
VASCULAR REGULATION BY FLOW VELOCITY/ENDOTHELIUM
通过流速/内皮调节血管
  • 批准号:
    6316702
  • 财政年份:
    2000
  • 资助金额:
    $ 43.64万
  • 项目类别:
CONTROL OF NO BY EXERCISE & INSULIN IN DIABETIC HEART
通过运动控制“不”
  • 批准号:
    6498973
  • 财政年份:
    2000
  • 资助金额:
    $ 43.64万
  • 项目类别:
NO/STEM CELLS IN THE DIABETIC HEART
糖尿病心脏中的无细胞/干细胞
  • 批准号:
    7211369
  • 财政年份:
    2000
  • 资助金额:
    $ 43.64万
  • 项目类别:
NO/STEM CELLS IN THE DIABETIC HEART
糖尿病心脏中的无细胞/干细胞
  • 批准号:
    6929997
  • 财政年份:
    2000
  • 资助金额:
    $ 43.64万
  • 项目类别:
NO/STEM CELLS IN THE DIABETIC HEART
糖尿病心脏中的无细胞/干细胞
  • 批准号:
    7393134
  • 财政年份:
    2000
  • 资助金额:
    $ 43.64万
  • 项目类别:
CONTROL OF NO BY EXERCISE & INSULIN IN DIABETIC HEART
通过运动控制“不”
  • 批准号:
    6044504
  • 财政年份:
    2000
  • 资助金额:
    $ 43.64万
  • 项目类别:
CONTROL OF NO BY EXERCISE & INSULIN IN DIABETIC HEART
通过运动控制“不”
  • 批准号:
    6351541
  • 财政年份:
    2000
  • 资助金额:
    $ 43.64万
  • 项目类别:
NO/STEM CELLS IN THE DIABETIC HEART
糖尿病心脏中的无细胞/干细胞
  • 批准号:
    7023880
  • 财政年份:
    2000
  • 资助金额:
    $ 43.64万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了